Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

[Lymphedema: which drug therapy?].

Identifieur interne : 000640 ( France/Analysis ); précédent : 000639; suivant : 000641

[Lymphedema: which drug therapy?].

Auteurs : V. Boursier [France]

Source :

RBID : pubmed:12162207

Descripteurs français

English descriptors

Abstract

Treatment of primary or secondary lymphedema includes essentially complex decongestive physiotherapy. For many years now, drugs active in reducing volume of lymphedema are prospected. But few studies are available. Only few drugs have been tested. Diuretics have been the first to be used with short and brief efficacy. Benzopyrones were the most tested product with encouraging but conflicting results. New treatments are proposed without randomized controlled studies. Prevention of lymphedema remains essential in particular after treatment of breast cancer.

PubMed: 12162207


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:12162207

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">[Lymphedema: which drug therapy?].</title>
<author>
<name sortKey="Boursier, V" sort="Boursier, V" uniqKey="Boursier V" first="V" last="Boursier">V. Boursier</name>
<affiliation wicri:level="3">
<nlm:affiliation>Unité de lymphologie, hôpital Cognacq-Jay, site Broussais, 102, rue Didot, 75014 Paris, France. virginie.boursier@voila.fr</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Unité de lymphologie, hôpital Cognacq-Jay, site Broussais, 102, rue Didot, 75014 Paris</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2002">2002</date>
<idno type="RBID">pubmed:12162207</idno>
<idno type="pmid">12162207</idno>
<idno type="wicri:Area/PubMed/Corpus">004507</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004507</idno>
<idno type="wicri:Area/PubMed/Curation">004507</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">004507</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004507</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">004507</idno>
<idno type="wicri:Area/Ncbi/Merge">000A64</idno>
<idno type="wicri:Area/Ncbi/Curation">000A64</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000A64</idno>
<idno type="wicri:doubleKey">0248-8663:2002:Boursier V:lymphedema:which:drug</idno>
<idno type="wicri:Area/Main/Merge">009629</idno>
<idno type="wicri:Area/Main/Curation">009310</idno>
<idno type="wicri:Area/Main/Exploration">009310</idno>
<idno type="wicri:Area/France/Extraction">000640</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">[Lymphedema: which drug therapy?].</title>
<author>
<name sortKey="Boursier, V" sort="Boursier, V" uniqKey="Boursier V" first="V" last="Boursier">V. Boursier</name>
<affiliation wicri:level="3">
<nlm:affiliation>Unité de lymphologie, hôpital Cognacq-Jay, site Broussais, 102, rue Didot, 75014 Paris, France. virginie.boursier@voila.fr</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Unité de lymphologie, hôpital Cognacq-Jay, site Broussais, 102, rue Didot, 75014 Paris</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">La Revue de medecine interne</title>
<idno type="ISSN">0248-8663</idno>
<imprint>
<date when="2002" type="published">2002</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Anticoagulants (therapeutic use)</term>
<term>Breast Neoplasms (complications)</term>
<term>Coumarins (therapeutic use)</term>
<term>Diuretics (therapeutic use)</term>
<term>Female</term>
<term>Flavonoids (therapeutic use)</term>
<term>Humans</term>
<term>Lymphedema (drug therapy)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Anticoagulants (usage thérapeutique)</term>
<term>Coumarines (usage thérapeutique)</term>
<term>Diurétiques (usage thérapeutique)</term>
<term>Femelle</term>
<term>Flavonoïdes (usage thérapeutique)</term>
<term>Humains</term>
<term>Lymphoedème (traitement médicamenteux)</term>
<term>Tumeurs du sein ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Anticoagulants</term>
<term>Coumarins</term>
<term>Diuretics</term>
<term>Flavonoids</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Anticoagulants</term>
<term>Coumarines</term>
<term>Diurétiques</term>
<term>Flavonoïdes</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Female</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Femelle</term>
<term>Humains</term>
<term>Tumeurs du sein</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Treatment of primary or secondary lymphedema includes essentially complex decongestive physiotherapy. For many years now, drugs active in reducing volume of lymphedema are prospected. But few studies are available. Only few drugs have been tested. Diuretics have been the first to be used with short and brief efficacy. Benzopyrones were the most tested product with encouraging but conflicting results. New treatments are proposed without randomized controlled studies. Prevention of lymphedema remains essential in particular after treatment of breast cancer.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>France</li>
</country>
<region>
<li>Île-de-France</li>
</region>
<settlement>
<li>Paris</li>
</settlement>
</list>
<tree>
<country name="France">
<region name="Île-de-France">
<name sortKey="Boursier, V" sort="Boursier, V" uniqKey="Boursier V" first="V" last="Boursier">V. Boursier</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000640 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000640 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    France
   |étape=   Analysis
   |type=    RBID
   |clé=     pubmed:12162207
   |texte=   [Lymphedema: which drug therapy?].
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/RBID.i   -Sk "pubmed:12162207" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024